Brief: Compugen Says Co Wins On PVRIG European Patent Opposition Pursued by GSK and a Third Party

Compugen

17/07/2023 12:17

July 17 (Reuters) - Compugen Ltd  CGEN.TA :
    * COMPUGEN - BROAD CLAIMS OF CO'S ANTI-PVRIG ANTIBODIES FOR
USE IN
TREATING CANCER PATENT GRANTED BY EUROPEAN PATENT OFFICE,
SUCCESSFULLY MAINTAINED
    * COMPUGEN - OPPOSITIONS WERE PURSUED BY GSK AND AN
ANONYMOUS
OPPONENT

Source text for Eikon:  ID: 
Further company coverage:  CGEN.TA 

 ((Reuters.Briefs@thomsonreuters.com;))